14-day Premium Trial Subscription Sign Up For FreeGet Free

AtriCure Stock Forecast NASDAQ:ATRC

Price Target and Analyst Ratings

Most Recent Rating

On August 05, 2021 "Canaccord Genuity" gave "$102.00 - $120.00" rating for ATRC. The price target was changed from $81.88 to 2.0%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-05 $102.00 - $120.00 Target Raised by Canaccord Genuity $81.47 $81.88→2.0%
2021-08-05 $91.00 - $90.00 Target Lowered by Needham & Company LLC $81.47 $81.88→2.0%
2021-08-05 $95.00 - $100.00 Target Raised by SVB Leerink $81.47 $81.88→2.0%
2021-08-05 Downgraded by Oppenheimer $81.47 $81.88→2.0%
2021-06-15 Positive - Buy Target Raised by Stifel Nicolaus $77.93 $72.00 → $85.00
2021-05-26 Outperform Target Raised by SVB Leerink $72.95 $78.00 → $95.00
2021-05-20 Overweight Target Raised by JPMorgan Chase & Co. $71.44 $70.00 → $81.00
2021-05-17 Buy Reiterated by Needham & Company LLC $72.60 $91.00
2021-05-14 Overweight Target Raised by JPMorgan Chase & Co. $72.00 $70.00 → $81.00
2021-05-04 Buy Target Raised by Canaccord Genuity $77.33 $77.00 → $102.00
2021-05-04 Outperform Target Raised by Oppenheimer $77.33 $65.00 → $75.00
2021-05-04 Buy Target Raised by Needham & Company LLC $77.33 $74.00 → $81.00
2021-04-29 Target Raised by Piper Sandler $76.00 $70.00 → $85.00
2021-04-29 Buy Reiterated by SVB Leerink $76.00
2021-04-28 Buy Target Raised by Canaccord Genuity $69.85 $77.00 → $102.00
2021-04-28 Buy Reiterated by Canaccord Genuity $69.85
2021-04-28 Buy Target Raised by BTIG Research $69.85 $69.00 → $76.00
2021-04-28 Outperform Target Raised by Oppenheimer $69.85 $65.00 → $75.00
2021-04-28 Buy Target Raised by Needham & Company LLC $69.85 $74.00 → $81.00
2021-04-12 Buy Target Raised by Canaccord Genuity $65.83 $69.00 → $77.00
2021-03-02 Buy Target Raised by Needham & Company LLC $66.73 $63.00 → $74.00
2021-03-02 Outperform Target Raised by SVB Leerink $66.73 $65.00 → $78.00
2021-02-24 Target Raised by SVB Leerink $62.41 $65.00 → $78.00
2021-02-24 Buy Target Raised by Canaccord Genuity $62.41 $53.00 → $69.00
2021-02-24 Buy Target Raised by Needham & Company LLC $62.41 $63.00 → $74.00
2021-01-29 Overweight Target Raised by Piper Sandler $58.23 $50.00 → $66.00
2021-01-21 In-Line - Buy Target Raised by BTIG Research $57.15 $56.00 → $66.00
2020-12-18 Buy Target Raised by Needham & Company LLC $54.89 $53.00 → $63.00
2020-12-14 Outperform Target Raised by SVB Leerink $48.13 $60.00 → $65.00
2020-11-06 Buy Target Lowered by Needham & Company LLC $36.71 $63.00 → $53.00
2020-07-29 Positive - Overweight Target Raised by Piper Sandler $42.38 $47.00 → $50.00
2020-07-29 Outperform Target Raised by SVB Leerink $42.38 $55.00 → $60.00
2020-07-29 Overweight Target Raised by JPMorgan Chase & Co. $42.38 $48.00 → $57.00
2020-07-28 Buy Reiterated by BTIG Research $44.67 $56.00
2020-05-11 Outperform Target Raised by Oppenheimer $46.03 $45.00 → $52.00
2020-05-11 Buy Target Raised by BTIG Research $46.03 $45.00 → $56.00
2020-05-11 Outperform Target Raised by SVB Leerink $46.03 $50.00 → $55.00
2020-05-08 Buy Reiterated by Needham & Company LLC $45.06 $49.00
2020-04-30 Buy Target Raised by Canaccord Genuity $43.12 $41.00 → $45.00
2020-04-29 Buy Reiterated by BTIG Research $41.39 $45.00
2020-04-28 Overweight Target Lowered by JPMorgan Chase & Co. $39.19 $47.00 → $39.00
2020-04-19 Outperform Initiated by Oppenheimer $39.83 $45.00
2020-04-13 Buy Target Lowered by Canaccord Genuity $37.35 $51.00 → $41.00

ATRC Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -6.86% during the next 3 months and, with a 90% probability hold a price between $64.94 and $75.75 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $69.63 $75.43 $81.23
2021-09-21 $69.53 $75.33 $81.13
2021-09-22 $69.44 $75.24 $81.04
2021-09-23 $69.34 $75.14 $80.94
2021-09-24 $69.25 $75.05 $80.85
2021-09-27 $69.15 $74.95 $80.75
2021-09-28 $69.06 $74.86 $80.66
2021-09-29 $68.96 $74.76 $80.56
2021-09-30 $68.87 $74.67 $80.47
2021-10-01 $68.77 $74.57 $80.37
2021-10-04 $68.68 $74.48 $80.28
2021-10-05 $68.58 $74.38 $80.18
2021-10-06 $68.49 $74.29 $80.09
2021-10-07 $68.39 $74.19 $79.99
2021-10-08 $68.30 $74.10 $79.90
2021-10-11 $68.20 $74.00 $79.80
2021-10-12 $68.11 $73.91 $79.71
2021-10-13 $68.01 $73.81 $79.61
2021-10-14 $67.92 $73.72 $79.52
2021-10-15 $67.82 $73.62 $79.42
2021-10-18 $67.73 $73.53 $79.33
2021-10-19 $67.63 $73.43 $79.23
2021-10-20 $67.54 $73.34 $79.14
2021-10-21 $67.44 $73.24 $79.04
2021-10-22 $67.35 $73.15 $78.95
2021-10-25 $67.25 $73.05 $78.85
2021-10-26 $67.16 $72.96 $78.76
2021-10-27 $67.06 $72.86 $78.66
2021-10-28 $66.97 $72.77 $78.57
2021-10-29 $66.87 $72.67 $78.47

About AtriCure

AtriCure AtriCure, Inc., a medical device company, provides atrial fibrillation solutions to hospitals and medical centers in the United States and internationally. The company offers Isolator Synergy System and related radio frequency(RF) ablation devices, which include clamps that are used for ablation during open-heart procedures; ablation and sensing unit, a compact power generator that delivers bipolar RF energy to its clamps, multifunctional pens, a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT